Influenza Vaccine Market 2020 Global Industry Trends, Size, Share Analysis to 2027 is latest report published on “Global Influenza Vaccine Market” by Fortune Business Insights. According to this report Global Influenza Vaccine Market will rise from Covid-19 crisis at moderate growth rate during 2020 to 2027. Report segments comprehensive information about Influenza Vaccine Market By Type (Inactivated and Live Attenuated), By Valency (Quadrivalent and Trivalent), By Age Group (Pediatric and Adults), By Distribution Channel (Hospital & Retail Pharmacies, Government Suppliers and Others) and Geography Forecast, 2020-2027.
Some of the companies operating the industry are:
- GlaxoSmithKline plc. (U.K, Europe)
- Sanofi S.A (France, Europe)
- AstraZeneca (Cambridge, United Kingdom)
- Seqirus (Maidenhead, UK)
- BioDiem (South Melbourne Victoria)
- Emergent BioSolutions Inc. (Maryland, United States)
- Hoffmann-La Roche Ltd (Basel, Switzerland)
- Sinovac Biotech Ltd (China).
Get Sample Copy of Global Influenza Vaccine Market Report
Influenza Vaccine Market Analysis From 2020 To 2027:
The global Influenza Vaccine market size is projected to reach 7.60 billion by 2027, exhibiting a CAGR of 6.9% during the forecast period. The increasing prevalence of chronic diseases and the growing death rate owing to influenza is propelling the government to promote immunization across the globe.
Influenza Vaccine Market includes comprehensive information derived from depth study on Influenza Vaccine Industry historical and forecast market data. Global Influenza Vaccine Market Size To Expand moderately as the new developments in Influenza Vaccine and Impact of COVID19 over the forecast period 2020 to 2027.
In June 2020, Seqirus announced the EU regulatory approval for its first-ever adjuvanted quadrivalent influenza vaccine for commercial sale across Europe. According to the company, the new vaccine adopts an advanced technology that has a higher-effectiveness in people aged 65 and above. Additionally, it is specially designed to provide protection against four strains of seasonal influenza such as two A strains and two B strains.
Additionally, the government agencies in collaboration with international healthcare organizations such as UNICEF, PAHO, and others are aiding in delivering effective influenza vaccine doses to prevent the spread of the disease. Such initiatives by the government are leading to the declining prevalence rate of several diseases. This is expected to bode well for the global flu vaccine market in the forthcoming years.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations travel bans and quarantines restaurants closed all indoor events restricted over forty countries state of emergency declared massive slowing of the IT Spending market volatility falling business confidence, growing panic among the population, and uncertainty about future.
The market is dominated by major companies such as Sanofi that have a full-fledged influenza vaccine portfolio and are further expanding their horizon by investing in the development of novel vaccines to gain a stronghold in the forthcoming years. Furthermore, the adoption of strategies such as merger and acquisition, partnerships, and collaboration by key players is expected to bode well for the growth of the market during the forecast period.
The Global Influenza Vaccine Market 2020 research provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Global Influenza Vaccine market report is provided for the international markets as well as development trends, competitive landscape analysis, and key regions development status. Development policies and plans are discussed as well as manufacturing processes and cost structures are also analyzed. This report additionally states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins.
Highlights of the Report:
- Market Penetration: Comprehensive information on the product portfolios of the top players in the Supply Chain Analytics market.
- Product Development/Innovation: Detailed insights on the upcoming technologies, RandD activities, and product launches in the market
- Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments of the leading players in the market
- Market Development: Comprehensive information about emerging markets. This report analyzes the market for various segments across geographies
- Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the Supply Chain Analytics market
Regional Market Overview:
North America generated a revenue of USD 2.18 billion in 2019 and is anticipated to dominate the influenza vaccine market share during the forecast period. The rapid development of efficient influenza vaccines, coupled with the usage of technologically advanced vaccine manufacturing systems across the region, is expected to drive the market growth in the region. Besides, the increasing influenza prevalence and the high sales of vaccines are further expected to fuel the growth of the market in North America. Moreover, the rising government funding, the presence of strong players, and sophisticated vaccination centers and hospitals will contribute to the stellar growth of the market.
This report focuses on Influenza Vaccine Global Market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. Regional analysis is another highly comprehensive part of the research and analysis study of the global market presented in the report. This section sheds light on the sales growth of different regional and country-level markets. For the historical and forecast period to 2024, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global market.
Competitive Analysis:
The Influenza Vaccine Market Size, Share, Growth report examines competitive scenario by analyzing key players in the market. The company profiling of leading market players is included this report with Porter’s five forces analysis and Value Chain analysis. Further, the strategies exercised by the companies for expansion of business through mergers, acquisitions, and other business development measures are discussed in the report. The financial parameters which are assessed include the sales, profits and the overall revenue generated by the key players of Market.
Key questions answered in the report:
- What will the market growth rate of Influenza Vaccine market in 2027?
- What are the key factors driving the global Influenza Vaccine market?
- Who are the key manufacturers in Influenza Vaccine market space?
- What are the market opportunities, market risk and market overview of the Influenza Vaccine market?
- What are sales, revenue, and price analysis of top manufacturers of Influenza Vaccine market?
- Who are the distributors, traders and dealers of Influenza Vaccine market?
- What are the Influenza Vaccine market opportunities and threats faced by the vendors in the global Influenza Vaccine industry?
- What are sales, revenue, and price analysis by types and applications of Influenza Vaccine market?
- What are sales, revenue, and price analysis by regions of Influenza Vaccine industry?
Table Of Content:
1 Market Overview
1.1 Influenza Vaccine Introduction
1.2 Market Analysis by Type
1.3 Market Analysis by Applications
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
3 Global Influenza Vaccine Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Influenza Vaccine Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Influenza Vaccine Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Influenza Vaccine Manufacturer Market Share in 2018
3.3.2 Top 6 Influenza Vaccine Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Influenza Vaccine Market Analysis by Regions
4.1 Global Influenza Vaccine Sales, Revenue and Market Share by Regions
4.1.1 Global Influenza Vaccine Sales and Market Share by Regions (2014-2019)
4.1.2 Global Influenza Vaccine Revenue and Market Share by Regions (2014-2019)
4.2 North America Influenza Vaccine Sales and Growth Rate (2014-2019)
4.3 Europe Influenza Vaccine Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Influenza Vaccine Sales and Growth Rate (2014-2019)
4.5 South America Influenza Vaccine Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Influenza Vaccine Sales and Growth Rate (2014-2019)
5 North America Influenza Vaccine by Country
5.1 North America Influenza Vaccine Sales, Revenue and Market Share by Country
5.1.1 North America Influenza Vaccine Sales and Market Share by Country (2014-2019)
5.1.2 North America Influenza Vaccine Revenue and Market Share by Country (2014-2019)
5.2 United States Influenza Vaccine Sales and Growth Rate (2014-2019)
5.3 Canada Influenza Vaccine Sales and Growth Rate (2014-2019)
5.4 Mexico Influenza Vaccine Sales and Growth Rate (2014-2019)
8 South America Influenza Vaccine by Country
8.1 South America Influenza Vaccine Sales, Revenue and Market Share by Country
8.1.1 South America Influenza Vaccine Sales and Market Share by Country (2014-2019)
8.1.2 South America Influenza Vaccine Revenue and Market Share by Country (2014-2019)
8.2 Brazil Influenza Vaccine Sales and Growth Rate (2014-2019)
8.3 Argentina Influenza Vaccine Sales and Growth Rate (2014-2019)
8.4 Colombia Influenza Vaccine Sales and Growth Rate (2014-2019)
9 Middle East and Africa Influenza Vaccine by Countries
9.1 Middle East and Africa Influenza Vaccine Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Influenza Vaccine Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Influenza Vaccine Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Influenza Vaccine Sales and Growth Rate (2014-2019)
9.3 Turkey Influenza Vaccine Sales and Growth Rate (2014-2019)
9.4 Egypt Influenza Vaccine Sales and Growth Rate (2014-2019)
9.5 Nigeria Influenza Vaccine Sales and Growth Rate (2014-2019)
10 Influenza Vaccine Market In Developing Conutries
11 South America Influenza Vaccine Market Analysis by Countries
12 Competitive Landscape
13 Industry Outlook
13.1 Market Driver Analysis
13.1.2 Market Restraints Analysis
13.1.3 Market Trends Analysis
13.2 Merger, Acquisition and New Investment
13.3 News of Product Release
14 Global Influenza Vaccine Market Forecast
15 New Project Feasibility Analysis
15.1 Industry Barriers and New Entrants SWOT Analysis
15.1.1 Porter’s Five Forces Analysis
15.1.2 New Entrants SWOT Analysis
15.2 Analysis and Suggestions on New Project Investment
Continued…
Related News:
Clinical Decision Support Systems Market
Hairy Cell Leukemia Therapeutics Market
Artificial Tendons and Ligaments Market
About Us:
Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.
At Fortune Business Insights™, we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.
Contact Us:
Fortune Business Insights Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune -411045, Maharashtra, India.
US: +1 424 253 0390
UK: +44 2071 939123
APAC: +91 744 740 1245
